Tel: 514–461–1300

Early Research Facility

Montreal Heart Institute (MHI) is a highly-specialized fully integrated academic hospital and leading research center with the expertise and facilities to conduct early phase clinical research.
This includes Phase I, first-in-human and proof-of-concept studies, both in healthy volunteers and patients.

Therapeutic areas:
Cardiology, metabolic diseases, prevention and risk factors for cardiovascular disease, neurology, oncology, dermatology, endocrinology, gastroenterology and pharmacogenomics. Specifically: hypertension, cholesterol, diabetes, insulin resistance, obesity, cardiovascular genetics, cognitive disorders, dementia, sophisticated brain imaging, metabolic and cardiovascular impacts of the microbiome.

• Drug studies (including new chemical entities and natural health products), diagnostics and medical devices;
• Access to specific patient populations such as patients with cardiovascular or metabolic diseases;
• 20-bed short-stay unit with specialized medical and nursing staff and 24/7 care including emergencies;
• Laboratory and central imaging services: echocardiography, ultrasound, Cardiac Magnetic Resonance (CMR) and CT scans;
• Supervision and operational services: central management, monitoring, data management, statistical analysis and reporting that meet regulatory standards and Good Clinical Practice (GCP).